Clinical trial

Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

NCT01844310

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2013-05-01

PhaseNA

Study timeline

Study start (unknown)2013-05-01Date precision: month

Registry last updated2013-05-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

AIDS/HIV PROBLEMunresolved

Interventions

RAL+TDF+LPV/rDRUG

3TC+TDF+LPV/rDRUG

Sponsors & collaborators

Peking Union Medical Collegelead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01844310 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.